Anti-PDCD1/PD-1/CD279 Antibody (Camrelizumab)
Catalog No.
F1339
Anti-PDCD1/PD-1/CD279 Antibody (Camrelizumab)
Featured Products
Camrelizumab (SHR-1210) is a humanized IgG4-κ antibodyPD-1 Camrelizumab binds to leukemia cells with a high affinity of 3 nM.PD-1 Bind, inhibitPD-1 andPD-L1 The combined effectIC50 Camrelizumab is a potent anti-PD-1/PD-L1 Active molecules that can be used in cancer research, including non-small cell lung cancer, esophageal squamous cell carcinoma, Hodgkin's lymphoma and advanced liver cancer.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.76 kDa
Dry ice
1798286-48-2
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
HR-301210, SHR 1210, INCSHR-1210
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q15116
Human, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human PD-1 His at 2 ug/mL can bind Anti-PDCD1/PD-1/CD279 Antibody (Camrelizumab)
PDCD1 / PD-1 / CD279
Please avoid freeze-thaw cycles.